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Abstract
Background: Although hippotherapy treatment has been demonstrated to have therapeutic effects on children with 
cerebral palsy, the samples used in research studies have been very small. In the case of hippotherapy simulators, there 
are no studies that either recommend or advise against their use in the treatment of children with cerebral palsy. The 
aim of this randomised clinical study is to analyse the therapeutic effects or the contraindications of the use of a 
commercial hippotherapy simulator on several important factors relating to children with cerebral palsy such as their 
motor development, balance control in the sitting posture, hip abduction range of motion and electromyographic 
activity of adductor musculature.
Methods/Design: The study is a randomised controlled trial. It will be carried out with a sample of 37 children with 
cerebral palsy divided into two treatment groups. Eligible participants will be randomly allocated to receive either (a) 
Treatment Group with hippotherapy simulator, maintaining sitting posture, with legs in abduction and rhythmic 
movement of the simulator or (b) Treatment Group maintaining sitting posture, with legs in abduction and without 
rhythmic movement of the simulator. Data collection and analysis: all measurements will be carried out by a specially 
trained blind assessor. To ensure standardization quality of the assessors, an inter-examiner agreement will be worked 
out at the start of the study. The trial is funded by the Department of Research, Innovation and Development of the 
Regional Government of Aragon (Official Bulletin of Aragon 23 July 2007), project number PM059/2007.
Discussion: Interest in this project is due to the following factors: Clinical originality (there are no previous studies 
analysing the effect of simulators on the population group of children with CP, nor any studies using as many variables 
as this project); Clinical impact (infantile cerebral palsy is a chronic multisystemic condition that affects not only the 
patient but also the patient's family and their close circle of friends); Practical benefits (the development of an effective 
treatment is very important for introducing this element into the rehabilitation of these children).
Trial registration: Current Controlled Trials ISRCTN03663478.
Background
Hippotherapy is a physical treatment strategy in which
the movement of a horse is used to improve posture, bal-
ance and general development of people with or without
motor difficulties. It has been used since the 1960s in
Europe and the mid 1970s in the USA for the treatment of
cerebral palsy (CP) as well as other neurological patholo-
gies such as multiple sclerosis, traumatic brain injury,
learning disabilities, muscular dystrophy and sensorial
problems. It is based on current theories of motor control
and development, and neurophysiological treatment
principles.
Several research studies have been published [1-13]
showing the beneficial effects of hippotherapy on patients
with disorders of the central nervous system, including
infantile CP. Current studies of the beneficial effects of
hippotherapy in the treatment of children with CP have a
scientific evidence level of 2a [14]. The main studies have
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been carried out on the basis that the horse's gait pro-
vides a precise, rhythmic and repetitive pattern of move-
ment similar to the movements of human walking [15].
Therefore, a patient whose disability has impeded the
development of a rhythmic walking pattern can be helped
to acquire reciprocal aspects of movement and to
improve posture control through the stimulation of nor-
mal balance reactions and through repetitive stimuli for
posture coordination during the hippotherapy session
[16,17].
The therapeutic results obtained with the application of
hippotherapy treatments has encouraged research into
developing an advanced hippotherapy platform or simu-
lators that "imitate" the movements of a horse, so that this
therapy may be more accessible and adaptable to patients.
A detailed study of the work developed in this line of
research or associated disciplines enables the following
classification to be drawn up of types of equine move-
ment simulators:
Structures of the Karakuri type [18,19] designed to give
the sensation of "riding a horse" and "trotting" by means
of a combination of forward-backward and up-and-down
oscillating movements. It is generally aimed for uses
requiring a great sensation of movement rather than fine
and precise adjustments [20].
Structures based on hexapods with geometry of parallel
platforms, with the upper platform being completely
moveable. Hexapods allow a greater degree of moveabil-
ity and adjustment, ideal for more precise movements at
the expense of greater structural complexity.
Technologies with specific mechanisms, such as those
developed by Matshushita (Panasonic) or Osim based on
the use of eccentric cams and followers (ad-hoc solution).
In any event, the development of mechanical simula-
tion systems for hippotherapy appears to be innovative
and not much exploited. There is no diversified work
within this research area.
In short, starting from existing studies about the bene-
fits of hippotherapy and taking into account the scarcity
of studies carried out with simulators (and none with
children with CP) the aim is to develop a study on the
effects of the use of a simulator with these children with
respect to two actions: remaining in the sitting position
(trunk stability) and influence on the hip joint, with the
simulator working providing a rhythmic movement imi-
tating a horse walking and with the simulator used simply
as a sitting device with no movement.
This study is especially novel for two reasons. First,
because the sample of children is substantially greater
than that of other published studies concerning tradi-
tional hippotherapy, and the study is not limited to less
serious cases. Second, because the therapeutic effect of a
hippotherapy simulator is to be studied on a population
group about whom no published data is available about
the use of simulators.
Objectives
The main objective to be achieved in this project is to
study the therapeutic relevance of a hippotherapy simula-
tor for the treatment of children with cerebral palsy (con-
sidering four outcome variables, which are: sitting
stability, muscle activity in hip adductors, range of hip
abduction mobility and global motor development). We
will study and divide the effect of the hippotherapy simu-
lator into two aspects:
- Maintenance of a therapeutic stance.
- Rhythmic and repetitive movement produced by the
simulator, that is similar to the normal mechanics of the
human step.
Methods
This study has been approved (reference number CP04/
06/08) by a Spanish Regional Ethics Committee (CEICA)
and consequently the study will be carried out in compli-
ance with the Helsinki Declaration of Human Rights.
Informed consent will be obtained from children's par-
ents or tutors prior to participating in the study.
Sample
The subjects of the study are children between 4 and 18
years old with CP, who attend schools run by the Educa-
tion Department of the Government of Aragon (Spain)
and whose tutors have signed an informed consent form.
Regarding the sample size, a calculation of statistical
power was made previous to the study. The calculation of
statistical power was based on a non-published introduc-
tory research of the effects of a commercialized hippo-
therapy simulator for cerebral palsy children. In this
study, an improvement of 60% was obtained in cases
against 10% of improvement in controls, so improvement
probability is considered to be at least double in cases
than in controls (odd ratio of 2). In order to assure a
power of 0.90 the sample should be 17 in every group
(total sample 34). The sample size was considered to be
10% greater due to possible drop-outs (37-38 children).
All CP children that fit the inclusion criteria were
selected to participate (37 children). In this study it is
h o ped  t o  as s i gn  a t  l e as t  1 8  s u b jects  r a n d o m l y  t o  e a c h
experimental condition.
In cases where tutors or children do not wish to partici-
pate, the following variables will be recorded: Sex, age,
level of Gross Motor Function Classification System and
cause to refuse to participate.
The exclusion criteria are as follows:
- Children who have undergone selective dorsal rhizo-
tomy
- Acute convulsions not controlled by medicationHerrero et al. BMC Musculoskeletal Disorders 2010, 11:71
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- Allergy to electrode adhesives
- Visual impairment not corrected with glasses
- Those circumstances or associated illnesses that in
the judgment of the researcher might interfere with the
results or be detrimental to the children.
- Inability to attend intervention sessions or refusal to
participate.
Study design
The study design is a randomised controlled trial. A
scheme of the study is shown in Figure 1.
The patients will be classified into five levels according
to the Gross Motor Function Classification System
(GMFCS) and subsequently randomly divided into two
treatment groups.
1.- Treatment Group with hippotherapy simulator
switched on.
2.- Treatment Group with hippotherapy simulator
switched off (without rhythmic movement).
The randomising will be centralised and generated by
computer according to stratified groups to ensure a simi-
lar distribution of the possible confounding variables in
both groups. The assignation sequence will be concealed.
Ten treatment sessions (one weekly) will be given in
each modality, in which the children will do different
activities proposed by the physiotherapist according to
their motor possibilities.
In the treatment sessions with the hippotherapy simu-
lator switched on, the children will maintain the sitting
position for 15 minutes on the simulator, with an active
extension of the trunk, stabilization of the pelvis and
abduction of hips while the simulator produces a rhyth-
mic and repetitive movement that is similar to a walking
horse. In the treatment sessions with the simulator
switched off (without providing the rhythmic move-
ment), the children will maintain the active extension of
the trunk, stabilization of the pelvis and abduction of hips
but they won't benefit from the rhythmic effects pro-
duced by the hippotherapy simulator. That is, the chil-
dren who sit on the simulator that is switched off will
receive the same treatment except that they won't receive
rhythmic movement from the simulator (it would be sim-
ilar to sitting on a barrel or another device in which they
maintain this sitting position, similar to other studies
published7).
Children not included in the group with the simulator
switched on will be offered the possibility to receive ten
more treatments with the simulator switched on once the
research has concluded.
Study variables
The hippotherapy simulator used for this study is "Core
Trainer Exercise Equipment, JOBA" produced by Mat-
Figure 1 Randomised controlled trial design.Herrero et al. BMC Musculoskeletal Disorders 2010, 11:71
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shuita (Panasonic), and allows working at 9 speeds and 3
predefined programmes (basic conditioning, waist, hips).
This simulator was designed to be used in fitness cen-
tres. To make it easier to use the system offers three auto-
mated training routines:
WORKOUT (Side-To-Side)
WAIST (Forward Tilt)
HIPS (Backward Tilt)
These training routines can automatically modify the
speed and tilt of each one of the training sub phases
When planning a work session with the JOBA commer-
cial Simulator, the time, tilt and speed adjustment allows
for unequivocally defining the test parameters. Therefore
using the same Simulator and knowing these parameters,
the repeatability of the test is totally guaranteed. In the
case of our study , we have listed the exact programme
that was used, which is Side-To-Side WORKOUT.
The study variables will be measured with the instru-
ments showed in table 1 (see table 1).
There are four outcome variables:
- Sitting balance
- Measurement of hip abduction range of motion
- Electromyographic activity in adductors
- Global motor development
The outcome variables will be measured at three differ-
ent times during the research. A first measurement will
be made at the beginning of the study, a second one when
the ten treatment sessions have concluded, and a third
measurement after the 3-month follow-up period. More-
over, two of these outcome variables (hip abduction range
of motion and Electromyographic activity in adductors)
will also be measured before and after each treatment
session.
Control of confounding variables (independent vari-
ables) will be carried out on each and everyone of the
outcome variables studied. The confounding variables
considered to be studied will be those listed below:
- Sociodemographic variables: sex, age and physical
activity.
- Clinical variables: oral anti-spascity medication treat-
ment, other medical treatments that could interfere with
the hippotherapy treatment (antiepileptic drugs, etc.),
medical diagnosis, previous experience in hippotherapy,
off-trial hippotherapy treatments, surgical interventions,
botulinum toxin injections and use of ortheses.
A questionnaire will be completed at the beginning of
the study that collects the confounding variables previ-
ously described. Monitoring will be carried out through-
out the duration of the study.
Data collection and analysis: all measurements will be
carried out by a specially trained blind method consul-
tant. It is a triple blind trial because patients, researchers
and statisticians were unaware of the group the subjects
of the study belonged to. To ensure standardization qual-
ity of the consultants, an inter-examiner agreement will
be worked out at the start of the study.
Statistical analysis
The data will be entered and analyzed with SPSS 14.0,
and the following statistical procedure will be under-
taken:
1. Descriptive analysis of defined variables.
2. Mean comparison tests for quantitative variables and
comparison of proportions for qualitative data, among
independent variables to check the comparability of the
groups.
3. Mean comparison tests for each outcome variable
according to the treatment group (differences pre-post
treatment in both treatment groups as well as differences
between them)
4. Multivariate analysis to determine the influence of
independent variables in the evolution of each outcome
variable.
A descriptive analysis of drop outs will also be made in
order to determine if there are correlating patterns.
Discussion
The interest in this project is due to the following factors:
- Clinical originality: there is no previous studies that
analyse the effect of simulators on the population group
of children with CP, nor that use as many variables as this
project. Furthermore, the sample under study is notice-
ably larger than others in the literature concerning tradi-
tional hippotherapy, and includes a greater range in terms
of the degree to which patients are affected.
- Clinical impact: infantile cerebral palsy is a chronic
multisystemic condition that affects not only the patient
but also the patient's family and their close circle of
friends. Affected children receive a large number of treat-
Table 1: Study variables and instruments for measurement.
STUDY VARIABLES INSTRUMENTS
Sitting balance SAS (Sitting Assessment 
Scale) [21]
Muscular activity in hip 
adductors
Surface Electromyography 
(EMG)
Hip abduction range of 
motion
Electronic inclinometer and 
traditional goniometer
Gross motor function Gross Motor Function 
Measure (GMFM)Herrero et al. BMC Musculoskeletal Disorders 2010, 11:71
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ments from a multi-disciplinary team (physiotherapists,
special needs teachers, speech therapists, occupational
therapists, etc). It is therefore important to make
advances in the clinical treatment of these children (espe-
cially through techniques that could be considered as rec-
reational) to improve their quality of life.
- Practical benefits: the development of an effective
treatment is very important for introducing this element
into the rehabilitation of these children. The effectiveness
of hippotherapy has already been demonstrated but in
many cases it is not possible to put it into practice for var-
ious reasons (fear, difficulty of mounting a horse, climate,
financial considerations, etc). In these circumstances, if
the use of simulators can be shown to be therapeutically
effective, it would benefit a considerable number of
patients.
- Increase in technological experience: the knowledge
acquired during the development of the project would
lead to further lines of research in very important areas
such as mobility, automated physiotherapy, and ergo-
nomic positioning measures.
- Social advantages: the opportunity of offering new
evidence-based treatments for infantile cerebral palsy is
of great interest at a social level not only for the benefits
to be derived from the therapy but also for the recre-
ational character of the activity and the possibility of
combining with other types of therapy.
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